Q3 2025 Management View CEO Justin Palfreyman emphasized strong progress on strategic goals, stating "We continue to expand ...
Marketing Authorization Applications for obicetrapib and FDC of obicetrapib plus ezetimibe accepted for review by European Medicines Agency –– ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback